ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 212 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $5,005,000 | +133.7% | 618,658 | +710.6% | 0.02% | +128.6% |
Q4 2021 | $2,142,000 | -54.4% | 76,324 | -44.8% | 0.01% | -65.0% |
Q3 2021 | $4,699,000 | +194.6% | 138,256 | +254.2% | 0.02% | +150.0% |
Q2 2021 | $1,595,000 | -46.6% | 39,034 | -22.7% | 0.01% | -52.9% |
Q4 2020 | $2,987,000 | -66.4% | 50,521 | -72.3% | 0.02% | -73.8% |
Q3 2020 | $8,881,000 | +778.4% | 182,634 | +773.7% | 0.06% | +622.2% |
Q2 2020 | $1,011,000 | -92.0% | 20,903 | -95.1% | 0.01% | -88.0% |
Q4 2019 | $12,689,000 | – | 424,087 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |